首页 | 本学科首页   官方微博 | 高级检索  
     

保肝消石胶囊的体外溶石、抑菌、解痉作用研究
引用本文:王张,孟宪丽,杨莉娟,熊玉霞. 保肝消石胶囊的体外溶石、抑菌、解痉作用研究[J]. 中国药房, 2006, 17(2): 98-101
作者姓名:王张  孟宪丽  杨莉娟  熊玉霞
作者单位:成都中医药大学药学院药理教研室,成都市,610075
摘    要:
目的:研究保肝消石胶囊的体外溶石、抑菌、解痉作用。方法:采用体外试验方法,观察保肝消石胶囊等药物对人胆色素结石、胆固醇结石、细菌和兔十二指肠平滑肌的影响。结果:浓度分别为7.568、15.135、30.270g(生药)/ml的保肝消石胶囊对人胆色素结石的溶石重量依次为5.4、8.3、14.7mg,对胆固醇结石的溶石重量依次为2.9、5.1、7.1mg,均有明显的体外溶解作用;对金黄色葡萄球菌、肠球菌、类白喉杆菌和溶血性链球菌有较强的抑制和杀灭作用,相应的最低抑菌浓度(MIC)依次为23.65、23.65、23.65、47.297mg(生药)/ml,最低杀菌浓度(MBC)均为47.297mg(生药)/ml;对大肠埃希菌、伤寒沙门菌及肺炎克雷伯菌均有一定的抑制和杀灭作用,MIC、MBC分别为378.375、756.75mg(生药)/ml;浓度为5.3414mg(生药)/ml的保肝消石胶囊能明显抑制乙酰胆碱所致肠肌收缩的平均张力增强、频率加快和活动度增加(P<0.01);浓度为3.5610、5.3414、7.1219mg(生药)/ml的保肝消石胶囊均能明显抑制氯化钡所致肠肌收缩的平均张力增强、频率加快和活动度增加(P<0.05或P<0.01)。结论:保肝消石胶囊具有一定的体外溶石、抑菌及解痉作用。

关 键 词:保肝消石胶囊  溶石  抑菌  解痉
文章编号:1001-0408(2006)02-0098-04
收稿时间:2005-08-01
修稿时间:2005-08-012005-09-21

The Litholytic,Bacteriostatic and Spasmolytic Effects of Baoganxiaoshi Capsule In Vitro
WANG Zhang,MENG Xianli,YANG Lijuan,XIONG Yuxia. The Litholytic,Bacteriostatic and Spasmolytic Effects of Baoganxiaoshi Capsule In Vitro[J]. China Pharmacy, 2006, 17(2): 98-101
Authors:WANG Zhang  MENG Xianli  YANG Lijuan  XIONG Yuxia
Affiliation:Pharmacology Research and Teaching Lab , Chengdu University of Traditional Chinese Medicine,Chengdu 610075,China
Abstract:
OBJECTIVE:To study the litholytic,bacteriostatic and spasmolytic effects of Baoganxiaoshi capsule(BXC) in vitro.METHODS:Observed the effects of BXC on human bile pigmental and cholesterol gallstone, bacteria, duodenum smooth muscle of rabbits in vitro.RESULTS:The litholytic concentration of 7.568,15.135 and 30.270g(crude drug)/ml solutions of BXC on human bile pigmental gallstone were 5.4mg,8.3 mg and 14.7 mg respectively,and on human bile cholesterol gallstone were 2.9mg,5.1 mg and 7.1 mg respectively.So BXC have the litholytic function of bile pigmental and cholesterol gallstone.It can strongly inhibit or sterilize staphylococcus aureus, enterococcus, diphtherial bacillus, hemo1ytic streptococcus, and the MICs were 23.65mg(crude drug)/ml ,23.65mg(crude drug)/ml,23.65mg(crude drug)/ml and 47.297mg(crude drug)/ml respectively, and all of the MBCs were 47.297mg(crude drug)/ml.It can inhibit or sterilize coliform,salmonella and pneumococcus, and all of the MICs were 378.375mg(crude drug)/ml, and all of the MBCs were 756.75mg(crude drug)/ml.5.3 414mg(crude drug)/ml solutions of BXC could obviously inhibit the average tension amplified,the frequency accelerated,and the activity increaced,on the duodenum smooth muscle induced by ach(P<0.01).3.5 610mg(crude drug)/ml,5.3 414mg(crude drug)/ml,7.1 219mg(crude drug)/ml solutions of BXC could obviously inhibit the average tension amplified,the frequency accelerated,and the activity increaced,on the duodenum smooth muscle induced by BaCl2(P<0.05 or P<0.01).CONCLUSION: BXC have the litholytic,bacteriostatic and spasmolytic effects in vitro.
Keywords:Baoganxiaoshi Capsule    Lithodiahsis    Bacteriostatic effect    Spasmolytic effect
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号